Unichem Laboratories (NSE:UNICHEMLAB) YoY EBITDA Growth: 191.32% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
72 GF Score
Price ₹526.15
GF Value ₹703.52
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Unichem Laboratories YoY EBITDA Growth?

Unichem Laboratories NSE:UNICHEMLAB +1.86% 72 YoY EBITDA Growth is 191.32% as of Jun. 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 72/100 and a GF Value™ of ₹703.52 (Modestly Undervalued). The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Unichem Laboratories's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 191.32%.

Unichem Laboratories's EBITDA per Share for the three months ended in Jun. 2026 was ₹12.15.

Unichem Laboratories YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories YoY EBITDA Growth Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.94 -139.57 229.33 395.32 49.92

Unichem Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.20 -54.85 235.45 -36.54 191.32
NSE:UNICHEMLAB
72GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Unichem Laboratories's YoY EBITDA Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (A: Mar. 2026 )
=(EBITDA per Share (A: Mar. 2026 )-EBITDA per Share (A: Mar. 2025 ))/ | EBITDA per Share (A: Mar. 2025 ) |
=(63.655-42.459)/ | 42.459 |
=49.92 %

Unichem Laboratories's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(12.151-4.171)/ | 4.171 |
=191.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 191.32% mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a YoY EBITDA Growth of 191.32% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Unichem Laboratories and its competitors.
Is Unichem Laboratories' YoY EBITDA Growth too high?
Unichem Laboratories' current YoY EBITDA Growth is 191.32%. Overall, Unichem Laboratories has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' YoY EBITDA Growth compare to ZTS?
Unichem Laboratories' YoY EBITDA Growth of 191.32% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Unichem Laboratories and its competitors. Unichem Laboratories's current YoY EBITDA Growth is 191.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹703.52, compared to a current price of ₹526.15 — trading 25.2% below its estimated fair value. The current YoY EBITDA Growth is 191.32%. Unichem Laboratories' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current YoY EBITDA Growth is 191.32% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹526.15 is trading 25.2% below its estimated GF Value™ of ₹703.52. GuruFocus considers Unichem Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:UNICHEMLAB:

  • YoY EBITDA Growth: 191.32%
  • GF Value™: ₹703.52 vs. price of ₹526.15 (25.2% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
72GF Score

Get the complete analysis for NSE:UNICHEMLAB

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹526.15
Price
₹703.52
GF Value